Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2146 to 2160 of 7679 results

  1. Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis

    Register an interest in this interventional procedure   ...

  2. Deep Brain Stimulation for Alzheimer

    Register an interest in this interventional procedure   ...

  3. Laparoscopic lumbar sympathectomy for foot hyperhidrosis

    Register an interest in this interventional procedure   ...

  4. Transarterial Chemoembolisation for inoperable hepatocellular carcinoma

    Register an interest in this interventional procedure   ...

  5. Neuromodulation for chronic pelvic pain

    Register an interest in this interventional procedure   ...

  6. CT guided fibrin glue sealing of CSf leak to treat spontaneous intracranial hypotension

    Register an interest in this interventional procedure   ...

  7. MRI guided transurethral high intensity ultrasound ablation of the prostate

    Register an interest in this interventional procedure   ...

  8. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Register an interest in this interventional procedure   ...

  9. Radiofrequency denervation for OA shoulder pain

    Register an interest in this interventional procedure   ...

  10. Implantable Vagus Nerve Stimulator in Heart Failure

    Register an interest in this interventional procedure   ...

  11. Cutting blocks for total knee arthroplasty

    Register an interest in this interventional procedure   ...

  12. Iodine (131I)–apamistamab for treating relapsed or refractory acute myeloid leukaemia before an allogeneic haematopoietic stem cell transplant [ID6355]

    In development [GID-TA11425] Expected publication date: TBC

  13. DCVax-L for treating glioblastoma [ID836]

    In development [GID-TA10143] Expected publication date: TBC

  14. Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular or marginal zone lymphoma after 1 or more anti-CD20 treatments ID6413

    Awaiting development [GID-TA11488] Expected publication date: TBC